Literature DB >> 2627949

Results of repeat angiography up to eight years following percutaneous transluminal angioplasty.

G Kober1, C Vallbracht, C Kadel, M Kaltenbach.   

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) has become a widely accepted procedure that provides acute and medium-term relief of anginal symptoms and myocardial ischaemia. The acute success rate has risen from about 50% in the early days to approximately 90% in recent years. Serial repeat angiograms obtained in different patient groups have shown a 20% incidence of angiographically defined restenosis in patients who had been successfully treated initially. Despite the restenosis, many of these patients were symptomatically improved since the lesions shown at follow-up angiography were often less severe than those that had existed prior to original PTCA. These figures suggest that a success rate of 80% at 1 year should now be a realistic expectation, especially when patients with repeat PTCA are included. None of the 87 patients re-angiographed between 2 and 8 years after successful PTCA developed restenosis after the first year of treatment. However, new stenoses of 50% or more were found in other vessel segments, in both symptomatic and asymptomatic patients, at a rate of about 7% per year.

Entities:  

Mesh:

Year:  1989        PMID: 2627949     DOI: 10.1093/eurheartj/10.suppl_g.49

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  3 in total

1.  Percutaneous coronary intervention in diabetics: time to consider "intimal remodelling therapy"?

Authors:  P F Ludman
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

Review 2.  Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.

Authors:  R N Brogden; P Benfield
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

Review 3.  Myocardial perfusion imaging after coronary revascularization: a clinical appraisal.

Authors:  Wanda Acampa; Maria Piera Petretta; Stefania Daniele; Pasquale Perrone-Filardi; Mario Petretta; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-20       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.